Johnson & Johnson (FRA:JNJ)
Germany · Delayed Price · Currency is EUR 158.20
+2.16 (1.38%)
Last updated: Oct 1, 2025, 10:24 AM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | Jan '21 Jan 3, 2021 | 2013 - 2020 |
Consumer Health | - | Log In | Log In | Log In | Log In | Upgrade |
Consumer Health Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Innovative Medicine | 56.96B | Log In | Log In | Log In | Log In | Upgrade |
Innovative Medicine Growth | 4.17% | Log In | Log In | Log In | Log In | Upgrade |
MedTech | 31.86B | Log In | Log In | Log In | Log In | Upgrade |
MedTech Growth | 5.60% | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Capex by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | Jan '21 Jan 3, 2021 | 2013 - 2020 |
Other | 271.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Consumer Health Capital Expenditures | - | Log In | Log In | Log In | Log In | Upgrade |
Consumer Health Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Innovative Medicine Capital Expenditures | 1.71B | Log In | Log In | Log In | Log In | Upgrade |
Innovative Medicine Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
MedTech Capital Expenditures | 2.44B | Log In | Log In | Log In | Log In | Upgrade |
MedTech Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 271.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 271.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | Jan '21 Jan 3, 2021 | 2013 - 2020 |
United States | 50.30B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 7.82% | Log In | Log In | Log In | Log In | Upgrade |
Europe | 20.21B | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | 1.33% | Log In | Log In | Log In | Log In | Upgrade |
Western Hemisphere ex-US | 4.71B | Log In | Log In | Log In | Log In | Upgrade |
Western Hemisphere ex-US Growth | -1.31% | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific, Africa | 13.59B | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific, Africa Growth | 0.58% | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | Jan '21 Jan 3, 2021 | 2013 - 2020 |
Other | -5.97B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -66.88% | Log In | Log In | Log In | Log In | Upgrade |
Other | -5.97B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -66.88% | Log In | Log In | Log In | Log In | Upgrade |
Consumer Health Income Before Tax | - | Log In | Log In | Log In | Log In | Upgrade |
Consumer Health Income Before Tax Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Innovative Medicine Income Before Tax | 18.92B | Log In | Log In | Log In | Log In | Upgrade |
Innovative Medicine Income Before Tax Growth | 1.70% | Log In | Log In | Log In | Log In | Upgrade |
MedTech Income Before Tax | 3.74B | Log In | Log In | Log In | Log In | Upgrade |
MedTech Income Before Tax Growth | 10.56% | Log In | Log In | Log In | Log In | Upgrade |
Other | -5.97B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -66.88% | Log In | Log In | Log In | Log In | Upgrade |
Sales % Change due to Transactions | 5.90 | Log In | Log In | Log In | Log In | Upgrade |
Sales % Change due to Transactions Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Sales % Change due to Price | - | Log In | Log In | Log In | Log In | Upgrade |
Sales % Change due to Price Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Sales % Change due to Currency | -1.60 | Log In | Log In | Log In | Log In | Upgrade |
Sales % Change due to Currency Growth | - | Log In | Log In | Log In | Log In | Upgrade |